These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 7555533)
1. Abnormal albuminuria as a predictor of mortality and renal impairment in Chinese patients with NIDDM. Chan JC; Cheung CK; Cheung MY; Swaminathan R; Critchley JA; Cockram CS Diabetes Care; 1995 Jul; 18(7):1013-6. PubMed ID: 7555533 [TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects. Bruno G; Cavallo-Perin P; Bargero G; Borra M; Calvi V; D'Errico N; Deambrogio P; Pagano G Diabetes Care; 1996 Jan; 19(1):43-7. PubMed ID: 8720532 [TBL] [Abstract][Full Text] [Related]
3. Evolution, risk factors, and prognostic implications of albuminuria in NIDDM. Niskanen LK; Penttilã I; Parviainen M; Uusitupa MI Diabetes Care; 1996 May; 19(5):486-93. PubMed ID: 8732714 [TBL] [Abstract][Full Text] [Related]
4. Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study. Nielsen S; Schmitz A; Poulsen PL; Hansen KW; Mogensen CE Diabetes Care; 1995 Nov; 18(11):1434-41. PubMed ID: 8722066 [TBL] [Abstract][Full Text] [Related]
5. Determinants of progression of microalbuminuria in patients with NIDDM.A prospective study. Smulders YM; Rakic M; Stehouwer CD; Weijers RN; Slaats EH; Silberbusch J Diabetes Care; 1997 Jun; 20(6):999-1005. PubMed ID: 9167114 [TBL] [Abstract][Full Text] [Related]
6. Microalbuminuria, Other Markers of Nephropathy and Biochemical Derangementsin Type 2 Diabetes Mellitus: Relationships and Determinants. Idowu AA; Ajose AO; Adedeji AT; Adegoke AO; Jimoh KA Ghana Med J; 2017 Jun; 51(2):56-63. PubMed ID: 28955101 [TBL] [Abstract][Full Text] [Related]
7. Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM). Chan JC; Cheung CK; Swaminathan R; Nicholls MG; Cockram CS Postgrad Med J; 1993 Mar; 69(809):204-10. PubMed ID: 8497435 [TBL] [Abstract][Full Text] [Related]
8. Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy. Imano E; Kanda T; Nakatani Y; Nishida T; Arai K; Motomura M; Kajimoto Y; Yamasaki Y; Hori M Diabetes Care; 1998 Dec; 21(12):2135-9. PubMed ID: 9839106 [TBL] [Abstract][Full Text] [Related]
9. Effect of age on the development or progression of albuminuria in non-insulin-dependent diabetes mellitus (NIDDM) without hypertension. Ohno T; Kato N; Shimizu M; Ishii C; Ito Y; Tomono S; Kawazu S; Murata K Diabetes Res; 1993; 22(3):115-21. PubMed ID: 8076444 [TBL] [Abstract][Full Text] [Related]
10. High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. Lu B; Wen J; Song XY; Dong XH; Yang YH; Zhang ZY; Zhao NQ; Ye HY; Mou B; Chen FL; Liu Y; Shen Y; Wang XC; Zhou LN; Li YM; Zhu XX; Hu RM Diabetes Res Clin Pract; 2007 Feb; 75(2):184-92. PubMed ID: 16893584 [TBL] [Abstract][Full Text] [Related]
11. Albuminuria and poor glycemic control predict mortality in NIDDM. Gall MA; Borch-Johnsen K; Hougaard P; Nielsen FS; Parving HH Diabetes; 1995 Nov; 44(11):1303-9. PubMed ID: 7589828 [TBL] [Abstract][Full Text] [Related]
12. Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn Study. Jager A; Kostense PJ; Nijpels G; Heine RJ; Bouter LM; Stehouwer CD Diabetologia; 1998 Jun; 41(6):694-700. PubMed ID: 9662052 [TBL] [Abstract][Full Text] [Related]
13. [Screening for microalbuminuria in diabetic patients in the primary health care system]. Farkas K; Noll E; Jermendy G Orv Hetil; 1997 Feb; 138(8):459-65. PubMed ID: 9139249 [TBL] [Abstract][Full Text] [Related]
14. Triglyceride-glucose index: A surrogate marker of homeostasis model assessment of insulin resistance to predict diabetic nephropathy. Khan S; Qayyum S; Khan MNA J Pak Med Assoc; 2024 May; 74(5):862-867. PubMed ID: 38783431 [TBL] [Abstract][Full Text] [Related]
16. Utility of untimed urinary albumin measurements in assessing albuminuria in black NIDDM subjects. Chaiken RL; Khawaja R; Bard M; Eckert-Norton M; Banerji MA; Lebovitz HE Diabetes Care; 1997 May; 20(5):709-13. PubMed ID: 9135931 [TBL] [Abstract][Full Text] [Related]
17. Practical aspects of measuring microalbuminuria in diabetic patients. Jermendy G; Farkas K; Nádas J; Daróczy A; Péterfai E Diabetes Nutr Metab; 2001 Aug; 14(4):195-200. PubMed ID: 11716288 [TBL] [Abstract][Full Text] [Related]
18. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes. Jeon YK; Kim MR; Huh JE; Mok JY; Song SH; Kim SS; Kim BH; Lee SH; Kim YK; Kim IJ J Korean Med Sci; 2011 Feb; 26(2):258-63. PubMed ID: 21286018 [TBL] [Abstract][Full Text] [Related]
19. Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes. Viana LV; Gross JL; Camargo JL; Zelmanovitz T; da Costa Rocha EP; Azevedo MJ J Diabetes Complications; 2012; 26(5):407-12. PubMed ID: 22677793 [TBL] [Abstract][Full Text] [Related]
20. Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy. Gilbert RE; Akdeniz A; Weitz S; Usinger WR; Molineaux C; Jones SE; Langham RG; Jerums G Diabetes Care; 2003 Sep; 26(9):2632-6. PubMed ID: 12941731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]